Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases
eLife · 15.04.2025 · 14
DOI: 10.7554/elife.105393 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift eLife, online erschienen am 15.04.2025. Verfasst von Eugenio Antonio Carrera Silva und 2 weiteren Autor:innen. Beteiligte Einrichtung: EACS and JP Institute of Experimental Medicine, National Scientific and Technical Research Council, National Academy of Medicine (IMEX-CONICET-ANM), …. Hauptthemen laut MEDLINE: Helminths, Inflammation, Immunity, Innate, Autoimmune Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (ANPCyT); Fondo para la Investigación Científica y Tecnológica (FO…, Fundación Florencio Fiorini, Argentina, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina.
Abstract (Originalsprache)
The gut biome, a complex ecosystem of micro- and macro-organisms, plays a crucial role in human health. A disruption in this evolutive balance, particularly during early life, can lead to immune dysregulation and inflammatory disorders. ‘Biome repletion’ has emerged as a potential therapeutic approach, introducing live microbes or helminth-derived products to restore immune balance. While helminth therapy has shown some promise, significant challenges remain in optimizing clinical trials. Factors such as patient genetics, disease status, helminth species, and the optimal timing and dosage of their products or metabolites must be carefully considered to train the immune system effectively. We aim to discuss how helminths and their products induce trained immunity as prospective to treat inflammatory and autoimmune diseases. The molecular repertoire of helminth excretory/secretory products (ESPs), which includes proteins, peptides, lipids, and RNA-carrying extracellular vesicles (EVs), underscores their potential to modulate innate immune cells and hematopoietic stem cell precursors. Mimicking natural delivery mechanisms like synthetic exosomes could revolutionize EV-based therapies and optimizing production and delivery of ESP will be crucial for their translation into clinical applications. By deciphering and harnessing helminth-derived products’ diverse modes of action, we can unleash their full therapeutic potential and pave the way for innovative treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- EACS and JP Institute of Experimental Medicine, National Scientific and Technical Research Council, National Academy of Medicine (IMEX-CONICET-ANM), Buenos Aires, Argentina.
- AEE Institute of Pharmacology, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
- National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.
ORCID-Profile: Eugenio Antonio Carrera Silva, Juliana Puyssegur, Andrea Emilse Errasti
Förderung
- Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (ANPCyT); Fondo para la Investigación Científica y Tecnológica (FO…
- Fundación Florencio Fiorini, Argentina
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina
Zitieren
APA
Carrera Silva, E. A., Puyssegur, J., & Errasti, A. E. (2025). Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases. eLife, 14. https://doi.org/10.7554/elife.105393
Vancouver
Carrera Silva EA, Puyssegur J, Errasti AE. Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases. eLife. 2025;14. doi:10.7554/elife.105393
BibTeX
@article{CarreraSilva2025,
author = {Carrera Silva, Eugenio Antonio and Puyssegur, Juliana and Errasti, Andrea Emilse},
title = {Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases},
journal = {eLife},
year = {2025},
volume = {14},
doi = {10.7554/elife.105393}
}
EUVIMED